Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved

BACKGROUNDS: Perioperative chemotherapy (PEC) and neoadjuvant chemotherapy (NAC) have become a vital part of locally advanced gastric cancer (LAGC) treatment, but the optimal duration of PEC has not been studied. The aim of this study was to demonstrate the possibility of duration reduction in PEC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zining, Wang, Yinkui, Shan, Fei, Ying, Xiangji, Zhang, Yan, Li, Shuangxi, Jia, Yongning, Miao, Rulin, Xue, Kan, Li, Zhemin, Li, Ziyu, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671134/
https://www.ncbi.nlm.nih.gov/pubmed/34926284
http://dx.doi.org/10.3389/fonc.2021.775166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671134/
https://www.ncbi.nlm.nih.gov/pubmed/34926284
http://dx.doi.org/10.3389/fonc.2021.775166

Ejemplares similares